In a video interview with UroToday, Jen-Jane Liu, M.D., discusses highlights of a session on muscle-invasive bladder cancer she led at the Society of Urologic Oncology meeting in Dallas, Texas, earlier this year.

A new study led by Andrew Emili, Ph.D., uncovers how small molecules within bacteria interact with proteins, revealing a network of molecular connections that could improve drug discovery and cancer research. “Our work in E. coli shows that small molecules interact dynamically with many proteins inside cells and change their behavior. In cancer cells, these interactions could be major drivers of tumor growth, proliferation and potentially even immune evasion,” he says.

A new study led by Andrew Emili, Ph.D., uncovers how small molecules within bacteria interact with proteins, revealing a network of molecular connections that could improve drug discovery and cancer research. “Our work in E. coli shows that small molecules interact dynamically with many proteins inside cells and change their behavior. In cancer cells, these interactions could be major drivers of tumor growth, proliferation and potentially even immune evasion,” he says.

Dan Hoover, M.D., speaks to OPB Think Out Loud about OHSU’s ECHO on addiction, whose reach grew by nearly 65% last year. “Seeing so much more interest was huge for us,” he says. “We’re increasing what we’re doing in response to the increasing need for substance use treatment.”

News outlets highlight the six new sneakers designed by this year’s Doernbecher Freestyle XX patient-designers, which will become available for retail purchase Jan. 25.

Riding Beyond, a program that aids breast cancer survivors with the help of horse therapy, receives more than $30,000 from the OHSU Knight Cancer Institute’s Community Partnership Program to build a referral program to help inform patients in Jackson and Josephine counties about emotional survivorship issues.

News outlets highlight the six new sneakers designed by this year’s Doernbecher Freestyle XX patient-designers, which will become available for retail purchase Jan. 25.

OHSU researchers have uncovered how a molecule found on certain bacteria may drive blood clotting in sepsis, a life-threatening condition that causes about 8 million deaths per year.

Tanaya Shree, M.D., Ph.D., is named one of the American Society of Hematology (ASH) Basic/Translational Research Junior Faculty scholar recipients. Funding is awarded to hematologists in the United States and Canada who conduct basic, translational, and clinical research that advances the understanding and treatment of blood disorders.

OHSU researchers have uncovered how a molecule found on certain bacteria may drive blood clotting in sepsis, a life-threatening condition that causes about 8 million deaths per year.